1. Home
  2. SLGL vs RGS Comparison

SLGL vs RGS Comparison

Compare SLGL & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • RGS
  • Stock Information
  • Founded
  • SLGL 1997
  • RGS 1922
  • Country
  • SLGL Israel
  • RGS United States
  • Employees
  • SLGL N/A
  • RGS N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • RGS Other Consumer Services
  • Sector
  • SLGL Health Care
  • RGS Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • RGS Nasdaq
  • Market Cap
  • SLGL 69.1M
  • RGS 70.8M
  • IPO Year
  • SLGL 2018
  • RGS 1991
  • Fundamental
  • Price
  • SLGL $29.01
  • RGS $27.40
  • Analyst Decision
  • SLGL
  • RGS
  • Analyst Count
  • SLGL 0
  • RGS 0
  • Target Price
  • SLGL N/A
  • RGS N/A
  • AVG Volume (30 Days)
  • SLGL 25.3K
  • RGS 28.7K
  • Earning Date
  • SLGL 08-15-2025
  • RGS 11-05-2025
  • Dividend Yield
  • SLGL N/A
  • RGS N/A
  • EPS Growth
  • SLGL N/A
  • RGS 20.23
  • EPS
  • SLGL N/A
  • RGS 46.10
  • Revenue
  • SLGL $23,931,000.00
  • RGS $210,134,000.00
  • Revenue This Year
  • SLGL N/A
  • RGS N/A
  • Revenue Next Year
  • SLGL $31.17
  • RGS N/A
  • P/E Ratio
  • SLGL N/A
  • RGS $0.63
  • Revenue Growth
  • SLGL 264.86
  • RGS 3.52
  • 52 Week Low
  • SLGL $4.01
  • RGS $15.00
  • 52 Week High
  • SLGL $30.98
  • RGS $30.29
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 65.45
  • RGS 63.38
  • Support Level
  • SLGL $23.15
  • RGS $27.50
  • Resistance Level
  • SLGL $30.98
  • RGS $30.00
  • Average True Range (ATR)
  • SLGL 2.27
  • RGS 1.33
  • MACD
  • SLGL 0.00
  • RGS -0.08
  • Stochastic Oscillator
  • SLGL 74.90
  • RGS 64.77

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: